These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26801880)

  • 21. Niacin protects against UVB radiation-induced apoptosis in cultured human skin keratinocytes.
    Lin F; Xu W; Guan C; Zhou M; Hong W; Fu L; Liu D; Xu A
    Int J Mol Med; 2012 Apr; 29(4):593-600. PubMed ID: 22246168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paradoxical effect of rapamycin on inflammatory stress-induced insulin resistance in vitro and in vivo.
    Yang P; Zhao Y; Zhao L; Yuan J; Chen Y; Varghese Z; Moorhead JF; Chen Y; Ruan XZ
    Sci Rep; 2015 Oct; 5():14959. PubMed ID: 26449763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of Mammalian Target of Rapamycin Pathway Activation in Basal Cell Carcinoma as a New Therapeutic Approach.
    Chang ALS; Brown R; Li S; Betancourt N; Teng J
    Am J Dermatopathol; 2024 Sep; 46(9):588-592. PubMed ID: 38648034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. eIF4B is a convergent target and critical effector of oncogenic Pim and PI3K/Akt/mTOR signaling pathways in Abl transformants.
    Chen K; Yang J; Li J; Wang X; Chen Y; Huang S; Chen JL
    Oncotarget; 2016 Mar; 7(9):10073-89. PubMed ID: 26848623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Akt/mTOR/p70S6K pathway is activated in IgA nephropathy and rapamycin may represent a viable treatment option.
    Tian J; Wang Y; Guo H; Li R
    Exp Mol Pathol; 2015 Dec; 99(3):435-40. PubMed ID: 26297427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mTOR-inhibitor Sirolimus decreases the cyclosporine-induced expression of the oncogene ATF3 in human keratinocytes.
    Schaper-Gerhardt K; Walter A; Schmitz-Rode C; Satzger I; Gutzmer R
    J Dermatol Sci; 2018 Nov; 92(2):172-180. PubMed ID: 30220530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity.
    deGraffenried LA; Friedrichs WE; Russell DH; Donzis EJ; Middleton AK; Silva JM; Roth RA; Hidalgo M
    Clin Cancer Res; 2004 Dec; 10(23):8059-67. PubMed ID: 15585641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Silibinin protects against photocarcinogenesis via modulation of cell cycle regulators, mitogen-activated protein kinases, and Akt signaling.
    Mallikarjuna G; Dhanalakshmi S; Singh RP; Agarwal C; Agarwal R
    Cancer Res; 2004 Sep; 64(17):6349-56. PubMed ID: 15342425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapamycin regulates Akt and ERK phosphorylation through mTORC1 and mTORC2 signaling pathways.
    Chen XG; Liu F; Song XF; Wang ZH; Dong ZQ; Hu ZQ; Lan RZ; Guan W; Zhou TG; Xu XM; Lei H; Ye ZQ; Peng EJ; Du LH; Zhuang QY
    Mol Carcinog; 2010 Jun; 49(6):603-10. PubMed ID: 20512842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Licochalcone A induces autophagy through PI3K/Akt/mTOR inactivation and autophagy suppression enhances Licochalcone A-induced apoptosis of human cervical cancer cells.
    Tsai JP; Lee CH; Ying TH; Lin CL; Lin CL; Hsueh JT; Hsieh YH
    Oncotarget; 2015 Oct; 6(30):28851-66. PubMed ID: 26311737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vertical inhibition of the mTORC1/mTORC2/PI3K pathway shows synergistic effects against melanoma in vitro and in vivo.
    Werzowa J; Koehrer S; Strommer S; Cejka D; Fuereder T; Zebedin E; Wacheck V
    J Invest Dermatol; 2011 Feb; 131(2):495-503. PubMed ID: 21048785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical application of rapamycin ointment ameliorates Dermatophagoides farina body extract-induced atopic dermatitis in NC/Nga mice.
    Yang F; Tanaka M; Wataya-Kaneda M; Yang L; Nakamura A; Matsumoto S; Attia M; Murota H; Katayama I
    Exp Dermatol; 2014 Aug; 23(8):568-72. PubMed ID: 24903639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Torin2 Potentiates Anticancer Effects on Adult T-Cell Leukemia/Lymphoma by Inhibiting Mammalian Target of Rapamycin.
    Watanabe T; Sato A; Kobayashi-Watanabe N; Sueoka-Aragane N; Kimura S; Sueoka E
    Anticancer Res; 2016 Jan; 36(1):95-102. PubMed ID: 26722032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells.
    Zakikhani M; Blouin MJ; Piura E; Pollak MN
    Breast Cancer Res Treat; 2010 Aug; 123(1):271-9. PubMed ID: 20135346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial Akt signaling is rate-limiting for rapamycin inhibition of mouse mammary tumor progression.
    Phung TL; Eyiah-Mensah G; O'Donnell RK; Bieniek R; Shechter S; Walsh K; Kuperwasser C; Benjamin LE
    Cancer Res; 2007 Jun; 67(11):5070-5. PubMed ID: 17545582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
    Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
    J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting mammalian target of rapamycin by rapamycin prevents tumor progression in an oral-specific chemical carcinogenesis model.
    Czerninski R; Amornphimoltham P; Patel V; Molinolo AA; Gutkind JS
    Cancer Prev Res (Phila); 2009 Jan; 2(1):27-36. PubMed ID: 19139015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histone Deacetylase Inhibitors Inhibit the Proliferation of Gallbladder Carcinoma Cells by Suppressing AKT/mTOR Signaling.
    Zhang P; Guo Z; Wu Y; Hu R; Du J; He X; Jiao X; Zhu X
    PLoS One; 2015; 10(8):e0136193. PubMed ID: 26287365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers.
    Zhou X; Tan M; Stone Hawthorne V; Klos KS; Lan KH; Yang Y; Yang W; Smith TL; Shi D; Yu D
    Clin Cancer Res; 2004 Oct; 10(20):6779-88. PubMed ID: 15501954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
    Vega F; Medeiros LJ; Leventaki V; Atwell C; Cho-Vega JH; Tian L; Claret FX; Rassidakis GZ
    Cancer Res; 2006 Jul; 66(13):6589-97. PubMed ID: 16818631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.